3.03
6.77%
-0.22
Galectin Therapeutics Inc 주식(GALT)의 최신 뉴스
Wall Street Breakfast: The Week Ahead
Seeking Alpha
Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
GlobeNewswire Inc.
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
The Motley Fool
UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
GlobeNewswire Inc.
자본화:
|
볼륨(24시간):